These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25791475)

  • 1. NELL-1 expression in benign and malignant bone tumors.
    Shen J; LaChaud G; Khadarian K; Shrestha S; Zhang X; Soo C; Ting K; Dry SM; James AW
    Biochem Biophys Res Commun; 2015 May; 460(2):368-74. PubMed ID: 25791475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin expression in skeletal sarcomas.
    Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
    Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation.
    Chen F; Walder B; James AW; Soofer DE; Soo C; Ting K; Zhang X
    Int Orthop; 2012 Oct; 36(10):2181-7. PubMed ID: 22797704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenic tumors of bone.
    Green JT; Mills AM
    Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NELL-1 expression in tumors of cartilage.
    Shen J; LaChaud G; Shrestha S; Asatrian G; Zhang X; Dry SM; Soo C; Ting K; James AW
    J Orthop; 2015 Dec; 12(Suppl 2):S223-9. PubMed ID: 27047227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ectopic study of tissue-engineered bone with Nell-1 gene modified rat bone marrow stromal cells in nude mice.
    Hu JZ; Zhang ZY; Zhao J; Zhang XL; Liu GT; Jiang XQ
    Chin Med J (Engl); 2009 Apr; 122(8):972-9. PubMed ID: 19493425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD138 (syndecan-1) expression in bone-forming tumors.
    Nunez AL; Siegal GP; Reddy VV; Wei S
    Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors.
    Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD
    J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
    Conner JR; Hornick JL
    Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors.
    Toma CD; Svoboda M; Arrich F; Ekmekcioglu C; Assadian O; Thalhammer T
    J Pineal Res; 2007 Sep; 43(2):206-13. PubMed ID: 17645699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
    Roessner A; Grundmann E
    Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of EDA+ and EDB+ fibronectin splice variants in bone.
    Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H
    Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoid-forming bone tumors : Morphology and current translational cell biology].
    Roessner A; Schoeder V; Smolle M; Haybäck J
    Pathologe; 2020 Mar; 41(2):123-133. PubMed ID: 32078700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
    Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
    Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.